Late April and early May are the most flourish times in Denmark. The leaves are sprouting on the trees, the grass is growing quickly, weeds are coming to life and in many places in Denmark the yellow ...

Copenhagen Municipality has completed its first comprehensive mapping of biodiversity across the city. The new report outlines areas where there is potential to preserve, improve, or expand ...

Hours before Trump announced he was pausing all tariffs except those on China, the EU voted to hit back with counter-tariffs ...

Eli Lilly's robust sales for Mounjaro and Zepbound along with its positive outlook for 2025 also work in its favor. Click ...

Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Greenland appointed its first Arctic ambassador on Friday, pledging to promote sustainable economic development for ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to increase production of its flagship glucagon-like peptide 1 receptor ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

As a pioneer in diabetes care, Novo Nordisk NVO claims 34% of the USD 80 billion-plus diabetes treatment market and roughly half of the insulin market, itself worth more than USD 15 billion.